[1] Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application[J]. Mol Cancer, 2009, 8(1): 102. DOI: 10.1186/1476-4598-8-102.
[2]Zhou T, Zhang G, Liu Z, et al. Overexpression of miR92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer[J]. Int J Colorectal Dis, 2013, 28(1): 19-24. DOI: 10.1007/s00384-012-1528-1.
[3]许欣宜, 杜冀晖, 龚慧, 等. microRNAs 在结直肠癌患者血清中的表达及其诊断价值[J]. 中华检验医学杂志, 2014, 37(9): 691-695. DOI: 10.3760/cma.j.issn.1009-9158.2014.09.013.
[4] Tsuchida A, Ohno S, Wu W, et al. miR92 is a key oncogenic component of the miR1792 cluster in colon cancer[J]. Cancer Sci, 2011, 102(12): 22642271. DOI: 10.1111/j.13497006.2011.02081.x.
[5] Tian L, Fang YX, Xue JL, et al. Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro[J]. PLoS One, 2013, 8(9): e75885. DOI: 10.1371/journal.pone.0075885.
[6] He G, Zhang L, Li Q, et al. miR92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation[J]. Biomed Pharmacother, 2014, 68(1): 25-30. DOI: 10.1016/j.biopha.2013.11.004.
[7] Song H, Zhang Y, Liu N, et al. miR92a3p exerts various effects in glioma and glioma stemlike cells specifically targeting CDH1/βcatenin and Notch1/Akt signaling pathways[J]. Int J Mol Sci, 2016, 17(11): 10. DOI: 10.3390/ijms17111799.
[8] Hu S, Liu L, Chang EB, et al. Butyrate inhibits proproliferative miR92a by diminishing cMycinduced miR1792a cluster transcription in human colon cancer cells[J]. Mol Cancer, 2015, 14: 180. DOI: 10.1186/s129430150450x.
[9] Ha M, Kim VN. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8): 509-524. DOI: 10.1038/nrm3838.
[10] Tie J, Fan D. Big roles of microRNAs in tumorigenesis and tumor development[J]. Histol Histopathol, 2011, 26(10): 1353-1361. DOI: 10.14670/HH26.1353.
[11] Lv H, Zhang Z, Wang Y, et al. MicroRNA92a promotes colorectal cancer cell growth and migration by inhibiting KLF4[J]. Oncol Res, 2016, 23(6): 283-290. DOI: 10.3727/096504016X14562725373833.
[12] Ghaleb AM, Elkarim EA, Bialkowska AB, et al. KLF4 suppresses tumor formation in genetic and pharmacological mouse models of colonic tumorigenesis[J]. Mol Cancer Res, 2016, 14(4): 385-396. DOI: 10.1158/1541-7786.MCR-15-0410.
[13] MezaSosa KF, PérezGarcía EI, CamachoConcha N, et al. MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4[J]. PLoS One, 2014, 9(9): e103987. DOI: 10.1371/journal.pone.0103987.
[14] Zhang W, Chen X, Kato Y, et al. Novel cross talk of Kruppellike factor 4 and betacatenin regulates normal intestinal homeostasis and tumor repression[J]. Mol Cell Biol, 2006, 26(6): 2055-2064. DOI: 10.1128/MCB.26.6.20552064.2006.
[15] Yu T, Chen X, Zhang W, et al. Regulation of the potential marker for intestinal cells, Bmi1, by βcatenin and the Zinc finger protein KLF4: implications for colon cancer[J]. J Biol Chem, 2012, 287(6): 3760-3768. DOI: 10.1074/jbc.M111.316349. |